Structural analysis identifies an escape route from the adverse lipogenic effects of liver X receptor ligands.
Belorusova, A.Y., Evertsson, E., Hovdal, D., Sandmark, J., Bratt, E., Maxvall, I., Schulman, I.G., Akerblad, P., Lindstedt, E.L.(2019) Commun Biol 2: 431-431
- PubMed: 31799433 
- DOI: 10.1038/s42003-019-0675-0
- Primary Citation of Related Structures:  
6S4T, 6S4U, 6S4N, 6S5K - PubMed Abstract: 
Liver X receptors (LXRs) are attractive drug targets for cardiovascular disease treatment due to their role in regulating cholesterol homeostasis and immunity. The anti-atherogenic properties of LXRs have prompted development of synthetic ligands, but these cause major adverse effects-such as increased lipogenesis-which are challenging to dissect from their beneficial activities ...